Cargando…

Development and validation of prognostic scoring in primary intestinal diffuse large B-cell lymphoma: a single-institution study of 184 patients

BACKGROUND: The incidence of primary intestinal diffuse large B-cell lymphoma (PI-DLBCL) is much lower than primary gastric DLBCL, and large-scale analyses on the clinical characteristics, molecular features, therapeutic strategies, and risk stratification have been seldomly performed in PI-DLBCL. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Xing, Zang, Lu, Zhao, Bing-Bing, Yi, Hong-Mei, Lu, Hai-Yang, Xu, Peng-Peng, Cheng, Shu, Li, Qin-Yu, Fang, Ying, Wang, Li, Zhao, Wei-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576653/ https://www.ncbi.nlm.nih.gov/pubmed/34790748 http://dx.doi.org/10.21037/atm-21-4761

Ejemplares similares

Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
por: Huo, Yu-Jia, et al.
Publicado: (2022)

Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell Lymphoma
por: Pan, Mengmeng, et al.
Publicado: (2021)

Surgical treatment for male prolactinoma: A retrospective study of 184 cases
por: Song, Yi-Jun, et al.
Publicado: (2017)

Is CONUT score a prognostic index in patients with diffuse large cell lymphoma?
por: AKGÜN ÇAĞLIYAN, Gülsüm, et al.
Publicado: (2021)

Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma
por: Fang, Ying, et al.
Publicado: (2023)

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma
por: Shen, Rong, et al.
Publicado: (2023)

An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era
por: Sun, Feifei, et al.
Publicado: (2018)

Diffuse large B-cell lymphoma: An institutional analysis
por: Gogia, Ajay, et al.
Publicado: (2018)

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
por: Lu, Ting-Xun, et al.
Publicado: (2019)

Localized primary gastrointestinal diffuse large B cell lymphoma received a surgical approach: an analysis of prognostic factors and comparison of staging systems in 101 patients from a single institution
por: Zhang, Shengting, et al.
Publicado: (2015)

184 Cross-institutional collaborations for health equity research at a CTSA
por: Whipple, Elizabeth C., et al.
Publicado: (2022)

Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B‐cell lymphoma
por: Shen, Rong, et al.
Publicado: (2020)

Integrative genome‐wide chromatin accessibility and transcriptome profiling of diffuse large B‐cell lymphoma
por: Fang, Ying, et al.
Publicado: (2022)

Prognostic Significance of Ribosome-related Genes Signature in Diffuse Large B Cell Lymphoma
por: Wu, Wenqi, et al.
Publicado: (2023)

Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma
por: Liang, Xiao-jie, et al.
Publicado: (2022)

Development and validation of a [(18)F]FDG PET/CT-based radiomics nomogram to predict the prognostic risk of pretreatment diffuse large B cell lymphoma patients
por: Li, Mingshan, et al.
Publicado: (2022)

International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma
por: Mu, Shidai, et al.
Publicado: (2021)

Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma
por: Hao, Xiaoxiao, et al.
Publicado: (2017)

MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma
por: Zhu, Fu-qiang, et al.
Publicado: (2016)

Identification of three small nucleolar RNAs (snoRNAs) as potential prognostic markers in diffuse large B‐cell lymphoma
por: Li, Mei‐wei, et al.
Publicado: (2022)

Risk Stratification Of Diffuse Large B-Cell Lymphoma With Interim PET/CT By Combining Deauville Scores And International Prognostic Index
por: Sun, Hongwei, et al.
Publicado: (2019)

Prognostic and Clinicopathological Value of Survivin in Diffuse Large B-cell Lymphoma: A Meta-Analysis
por: Zhang, Ya, et al.
Publicado: (2015)

Expression of microRNA-184 in glioma
por: Wu, Xiao-Ben, et al.
Publicado: (2018)

Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma
por: Go, Se-Il, et al.
Publicado: (2023)

JNK pathway plays a key role in the immune system of the pea aphid and is regulated by microRNA-184
por: Ma, Li, et al.
Publicado: (2020)

Deformation change between $^{184m}$Au and $^{184g}$Au
por: Roussière, B, et al.
Publicado: (1998)

A Prognostic Model of Gastrointestinal Diffuse Large B Cell Lymphoma
por: Gao, Fan, et al.
Publicado: (2021)

B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study
por: Xu, Peng-Peng, et al.
Publicado: (2017)

A modified prognostic model in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
por: Zhao, Peiqi, et al.
Publicado: (2021)

miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphoma
por: Wang, Xinyuan, et al.
Publicado: (2020)

A nomogram prognostic model for diffuse large B‐cell lymphoma based on SUVmax and GNRI in elderly patients
por: Li, Maoqin, et al.
Publicado: (2023)

Primary hepatic diffuse large B cell lymphoma: A case report: Primary hepatic diffuse large B cell lymphoma
por: Ma, Yuan-Ji, et al.
Publicado: (2011)

A novel prognostic model based on four circulating miRNA in diffuse large B‐cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression
por: Sun, Rui, et al.
Publicado: (2020)

Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma
por: Xiong, Fei, et al.
Publicado: (2021)

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes
por: Sun, Yao, et al.
Publicado: (2016)

Identification of a prognostic metabolic gene signature in diffuse large B‐cell lymphoma
por: Wang, Huizhong, et al.
Publicado: (2021)

PS184: a study of antiproton-nucleus interactions at LEAR
por: Garreta, D, et al.
Publicado: (1984)

Prognostic Significance of p53 and p63 in Diffuse Large B-Cell Lymphoma: A Single-Institution Experience
por: Moreno, Juan Carlos Alvarez, et al.
Publicado: (2023)

Immune Characteristics of Chinese Diffuse Large B-Cell Lymphoma Patients: Implications for Cancer Immunotherapies
por: Xu, Peng-peng, et al.
Publicado: (2018)

Predictive Significance of a New Prognostic Score for Patients With Diffuse Large B-Cell Lymphoma in the Interim-Positron Emission Tomography Findings
por: Kong, Yu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ohselhmublq2llppmeciqtabf5